AI generated summary of Pubmed citation/abstract with PMID 38093447

https://pubmed.ncbi.nlm.nih.gov/38093447
Sixteen months of triheptanoin treatment in two patients with long-chain fatty acid oxidation disorders resulted in decreased rhabdomyolysis crises, lower maximum CK values, and significant weight gain, with no major side effects.